Targeted protein degradation: A promise for undruggable proteins

被引:164
作者
Samarasinghe, Kusal T. G. [1 ]
Crews, Craig M. [1 ,2 ,3 ]
机构
[1] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA
[2] Yale Univ, Dept Mol, New Haven, CT 06511 USA
[3] Yale Univ, Dept Pharmacol, New Haven, CT 06511 USA
关键词
CHEMICALLY-INDUCED DEGRADATION; TYROSINE KINASE ACTIVATION; BETA-CATENIN; SELECTIVE DEGRADATION; CHIMERIC MOLECULES; PROTAC DESIGN; CANCER; RESISTANCE; INHIBITORS; UBIQUITINATION;
D O I
10.1016/j.chembiol.2021.04.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein homeostasis, or "proteostasis," is indispensable for a balanced, healthy environment within the cell. However, when natural proteostasis mechanisms are overwhelmed from excessive loads of dysregulated proteins, their accumulation can lead to disease initiation and progression. Recently, the induced degradation of such disease-causing proteins by heterobifunctional molecules, i.e., PROteolysis TArgeting Chimeras (PROTACs), is emerging as a potential therapeutic modality. In the 2 decades since the PROTAC concept was proposed, several additional Targeted Protein Degradation (TPD) strategies have also been explored to target previously undruggable proteins, such as transcription factors. In this review, we discuss the progress and evolution of the TPD field, the breadth of the proteins targeted by PROTACs and the biological effects of their degradation.
引用
收藏
页码:934 / 951
页数:18
相关论文
共 183 条
[1]   PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase [J].
Adhikari, Bikash ;
Bozilovic, Jelena ;
Diebold, Mathias ;
Schwarz, Jessica Denise ;
Hofstetter, Julia ;
Schroeder, Martin ;
Wanior, Marek ;
Narain, Ashwin ;
Vogt, Markus ;
Dudvarski Stankovic, Nevenka ;
Baluapuri, Apoorva ;
Schoenemann, Lars ;
Eing, Lorenz ;
Bhandare, Pranjali ;
Kuster, Bernhard ;
Schlosser, Andreas ;
Heinzlmeir, Stephanie ;
Sotriffer, Christoph ;
Knapp, Stefan ;
Wolf, Elmar .
NATURE CHEMICAL BIOLOGY, 2020, 16 (11) :1179-+
[2]   Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia [J].
Ahn, Inhye E. ;
Underbayev, Chingiz ;
Albitar, Adam ;
Herman, Sarah E. M. ;
Tian, Xin ;
Maric, Irina ;
Arthur, Diane C. ;
Wake, Laura ;
Pittaluga, Stefania ;
Yuan, Constance M. ;
Stetler-Stevenson, Maryalice ;
Soto, Susan ;
Valdez, Janet ;
Nierman, Pia ;
Lotter, Jennifer ;
Xi, Liqiang ;
Raffeld, Mark ;
Farooqui, Mohammed ;
Albitar, Maher ;
Wiestner, Adrian .
BLOOD, 2017, 129 (11) :1469-1479
[3]  
Alabi S., 2020, MUTANT SELECTIVE DEG
[4]   Developing potent PROTACs tools for selective degradation of HDAC6 protein [J].
An, Zixuan ;
Lv, Wenxing ;
Su, Shang ;
Wu, Wei ;
Rao, Yu .
PROTEIN & CELL, 2019, 10 (08) :606-609
[5]   AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer [J].
Antonarakis, Emmanuel S. ;
Lu, Changxue ;
Wang, Hao ;
Luber, Brandon ;
Nakazawa, Mary ;
Roeser, Jeffrey C. ;
Chen, Yan ;
Mohammad, Tabrez A. ;
Chen, Yidong ;
Fedor, Helen L. ;
Lotan, Tamara L. ;
Zheng, Qizhi ;
De Marzo, Angelo M. ;
Isaacs, John T. ;
Isaacs, William B. ;
Nadal, Rosa ;
Paller, Channing J. ;
Denmeade, Samuel R. ;
Carducci, Michael A. ;
Eisenberger, Mario A. ;
Luo, Jun .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (11) :1028-1038
[6]   Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the Reality [J].
Arkin, Michelle R. ;
Tang, Yinyan ;
Wells, James A. .
CHEMISTRY & BIOLOGY, 2014, 21 (09) :1102-1114
[7]   A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo [J].
Bai, Longchuan ;
Zhou, Haibin ;
Xu, Renqi ;
Zhao, Yujun ;
Chinnaswamy, Krishnapriya ;
McEachern, Donna ;
Chen, Jianyong ;
Yang, Chao-Yie ;
Liu, Zhaomin ;
Wang, Mi ;
Liu, Liu ;
Jiang, Hui ;
Wen, Bo ;
Kumar, Praveen ;
Meagher, Jennifer L. ;
Sun, Duxin ;
Stuckey, Jeanne A. ;
Wang, Shaomeng .
CANCER CELL, 2019, 36 (05) :498-+
[8]   THE DISCOVERY OF LYSOSOMES [J].
BAINTON, DF .
JOURNAL OF CELL BIOLOGY, 1981, 91 (03) :S66-S76
[9]   BET inhibitors induce apoptosis through a MYC independent mechanism and synergise with CDK inhibitors to kill osteosarcoma cells [J].
Baker, Emma K. ;
Taylor, Scott ;
Gupte, Ankita ;
Sharp, Phillip P. ;
Walia, Mannu ;
Walsh, Nicole C. ;
Zannettino, Andrew C. W. ;
Chalk, Alistair M. ;
Burns, Christopher J. ;
Walkley, Carl R. .
SCIENTIFIC REPORTS, 2015, 5
[10]   ANCIENT DIVERGENCE AMONG BACTERIA [J].
BALCH, WE ;
MAGRUM, LJ ;
FOX, GE ;
WOLFE, RS ;
WOESE, CR .
JOURNAL OF MOLECULAR EVOLUTION, 1977, 9 (04) :305-311